Previous policy allowed up to a 12-month delay before articles were required to be made available to the public for free ...

We knew taxpayers were getting nickel and dimed but blindly mailing $145,000 in cash is shocking even for Washington,” Sen.

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

Milk not declared as an allergen was found in a Tennessee-based manufacturer's confectionery, not the first time candy has been recalled in the U.S. in 2025.

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...

Missouri Sen. Josh Hawley issued a letter on Monday urging the U.S. Food and Drug Administration (FDA) to reinstate safety ...

Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global ...

For the second time in recent months, the Food and Drug Administration is bringing back some recently fired employees, ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...